胚胎干细胞、成体干细胞、肿瘤干细胞、间充质干细胞与 iPSCs（含 iPSC 衍生细胞），配套专用培养基与诱导方案。 共 669 个产品。
Explore ImmunoClone's HighQC™ Human iPSC-Derived Natural Killer Cells (PBMC) for cutting-edge research. Elevate your projects with our premium cell solutions.
Human iPSC-derived neural progenitor cells from Accegen support long-term CNS studies, disease modeling, and reliable neuronal differentiation.
HighQC™ Human IPSC-Derived Neural Stem Cell offers integration-free NSCs from mRNA iPSCs for neurodevelopment, disease modeling, and drug testing.
HighQC™ Human IPSC-Derived Neural Stem Cell LRRK2 G2019S HET supports Parkinson’s disease modeling, LRRK2 pathway analysis, and neurodegeneration research.
HighQC™ Human IPSC-Derived Neural Stem Cell LRRK2 G2019S HOM models Parkinson’s, enabling LRRK2 signaling, neurodegeneration, and drug screening.
HighQC™ Human IPSC-Derived Neural Stem Cell MAPT P301L HET models tauopathy for neurodegeneration research using CRISPR-edited heterozygous P301L mutation.
Advance HighQC™ Human IPSC-Derived Neural Stem Cell MAPT P301L HOM for tauopathy modeling, neurodegenerative disease research, and drug discovery.
HighQC™ Human IPSC-Derived Neural Stem Cell MAPT R406W HET models tauopathy for neurodegeneration studies, enabling CRISPR-edited NSC assays in vitro.
HighQC™ Human IPSC-Derived Neural Stem Cell MAPT R406W HOM models tauopathy using homozygous MAPT R406W iPSC-derived NSCs for Alzheimer’s disease studies.
HighQC™ Human IPSC-Derived Neural Stem Cell MAPT V337M HET for tauopathy and Alzheimer’s research, featuring CRISPR-edited heterozygous MAPT mutation.
HighQC™ Human IPSC-Derived Neural Stem Cell MAPT V337M HOM models tauopathy for neurodegeneration research, edited by CRISPR and homozygous for V337M.
HighQC™ Human IPSC-Derived Neural Stem Cell-Alzheimer’s Disease Patient (APOE4 HOM) supports neurodegeneration modeling and APOE4-associated studies.
HighQC™ Human IPSC-Derived Neural Stem Cell from Alzheimer’s Disease Patient (PSEN1 A246E), ideal for studying Alzheimer’s disease and related therapies.
HighQC™ iPSC-Derived Neural Stem Cells (PSEN1 L286V) model Alzheimer’s pathology with a familial mutation background, ideal for CNS drug discovery.
HighQC™ Human IPSC-Derived Neural Stem Cell-Alzheimer’s Disease Patient (PSEN1 M146L) supports studies of APP processing, neuronal loss, and dementia.
HighQC™ Human IPSC-Derived Neural Stem Cell (Alzheimer’s, PSEN2 N141I) supports neurodegeneration modeling, PSEN2 mutation analysis, and AD drug testing.
Utilize HighQC™ Human IPSC-Derived Neural Stem Cell-Epilepsy Patient to model epilepsy-specific neurogenesis and evaluate CNS therapeutic responses.
HighQC™ Human IPSC-Derived Neural Stem Cell-Trisomy X Patient enables neurological disease modeling and neural development studies in Trisomy X contexts.
HighQC™ Human Neural Stem Cell Line supports studies of neurogenesis, neural differentiation, and regenerative modeling under defined in vitro conditions.
HighQC™ Human iPSC-Derived Neural Stem Cells – Huntington’s Disease Patient (CAG50) are optimized for modeling neurodegeneration and therapeutic screening.
Human iPSC-derived Oligodendrocyte-like Cells support neurodegeneration research with fast-maturing, marker-positive cells and sterility and QC testing.
HighQC™ Human iPSC-derived Phagocytes provide a standardized model for immune research, drug discovery, and functional assays of phagocytic activity.
Human iPSC-Derived Schwann Cell provides reliable in vitro models for myelination, neurobiology, regenerative medicine, and neurological drug testing.
HighQC™ Human iPSC-derived Sensory Neurons enable research into neurodegenerative diseases, sensory neuron function, and pharmacological screening.
共 669 个产品 ｜ 第 14 / 28 页
